Skip to content

Clinical trials

Phase 1 Recurrence trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1 Country / region: United States Clear all

448 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20014
20022
20033
20047
200512
200612
200710
200816
200916
201010
201119
201219
201313
201429
201518
201630
201717
201824
201921
202017
202125
202226
202329
202417
202521
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed213
Terminated104
Recruiting69
Active, not recruiting36
Withdrawn14
Unknown status7
Not yet recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)19
Celgene17
Memorial Sloan Kettering Cancer Center14
AbbVie13
M.D. Anderson Cancer Center13
Therapeutic Advances in Childhood Leukemia Consortium9
Baylor College of Medicine8
H. Lee Moffitt Cancer Center and Research Institute8
Dana-Farber Cancer Institute7
Daiichi Sankyo6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence448
Leukemia, Myeloid, Acute78
Multiple Myeloma65
Neoplasms63
Precursor Cell Lymphoblastic Leukemia-Lymphoma59
Lymphoma56
Lymphoma, Non-Hodgkin51
Neoplasm Metastasis46
Leukemia44
Burkitt Lymphoma40

Trials

Showing 1 to 25 of 448. Each trial links to its page on Pharma Observatory.

348 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.